Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rapid intravenous (iv) infusion of protamine sulfate is associated with hypotension in humans. A possible mechanism for this hypotension is the release of inflammatory mediators, including histamine, from tissue mast cells lining the blood vessels. To determine whether protamine caused nonimmunologic release of histamine, histamine released from dispersed human skin mast cells exposed to protamine sulfate was measured. Skin from seven adult patients was washed, chopped into small tissue fragments, and incubated with collagenase,
hyaluronidase
, and DNAase. Dispersed mast cells were harvested after 12 h of short-term tissue culture, washed, and challenged with protamine sulfate. Histamine release was measured using an automated histamine analyzer and expressed as a per cent of total released histamine measured minus the spontaneous histamine release. Spontaneous histamine release averaged 6 +/- 1%.
Protamine
produced dose-related histamine release. At a concentration of 3 X 10(-3) M, protamine sulfate released 14 +/- 2% (P less than 0.05), which significantly differed from spontaneous release. This study demonstrates that protamine sulfate causes nonimmunologic histamine release in dispersed human skin mast cells. However, histamine release occurred only at concentrations much greater than those used in clinical practice. Thus, these data do not support the hypothesis that nonimmunologic histamine release is a likely mechanism for protamine-induced hypotension in vivo.
...
PMID:Protamine-induced histamine release in human skin mast cells. 169 14
We undertook studies in the isolated perfused rat lung to determine 1) the effects of endothelial charge neutralization with the polycation protamine sulfate on microvascular permeability, lung water, and anionic ferritin binding to the endothelium and 2) the role of heparan sulfate and hyaluronate, negatively charged cell surface glycosaminoglycans, on permeability. Capillary permeability was determined by tissue 125I-albumin accumulation in isolated perfused rat lungs. In control lungs the 5-min albumin uptake was 0.50 +/- 0.05 cm3.s-1.g dry tissue-1 X 10(-3). It was increased by 132 +/- 7.8% (P less than 0.001) by protamine (0.08 mg/ml) and 65 +/- 12% (P less than 0.01) by heparinase (5 U/ml), whereas
hyaluronidase
(25 NFU/ml) was without effect. In control lungs total water was 4.83 +/- 0.15 ml g/dry tissue.
Protamine
increased lung water 12 +/- 2% (P less than 0.05). Heparinase caused a 9 +/- 3% increase (P less than 0.05), and
hyaluronidase
had no effect. Electron microscopy demonstrated that protamine increased anionic ferritin binding to the surface of endothelial cells. We conclude that protamine sulfate neutralization of negative charge in the pulmonary microcirculation leads to increased microvascular permeability. Heparin sulfate may be responsible for this charge effect.
...
PMID:Effects of protamine, heparinase, and hyaluronidase on endothelial permeability and surface charge. 369 32